93 related articles for article (PubMed ID: 34558198)
1. Combining meta-epidemiological study datasets on commercial funding of randomised clinical trials: Database, methods, and descriptive results of the COMFIT study.
Nejstgaard CH; Lundh A; Abdi S; Clayton G; Gelle MHA; Laursen DRT; Olorisade BK; Savović J; Hróbjartsson A;
Res Synth Methods; 2022 Mar; 13(2):214-228. PubMed ID: 34558198
[TBL] [Abstract][Full Text] [Related]
2. Commercial funding and estimated intervention effects in randomized clinical trials: Systematic review of meta-epidemiological studies.
Nejstgaard CH; Laursen DRT; Lundh A; Hróbjartsson A
Res Synth Methods; 2023 Mar; 14(2):144-155. PubMed ID: 36357935
[TBL] [Abstract][Full Text] [Related]
3. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
Savović J; Jones H; Altman D; Harris R; Jűni P; Pildal J; Als-Nielsen B; Balk E; Gluud C; Gluud L; Ioannidis J; Schulz K; Beynon R; Welton N; Wood L; Moher D; Deeks J; Sterne J
Health Technol Assess; 2012 Sep; 16(35):1-82. PubMed ID: 22989478
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.
Abraha I; Cherubini A; Cozzolino F; De Florio R; Luchetta ML; Rimland JM; Folletti I; Marchesi M; Germani A; Orso M; Eusebi P; Montedori A
BMJ; 2015 May; 350():h2445. PubMed ID: 26016488
[TBL] [Abstract][Full Text] [Related]
6. Assessing bias in osteoarthritis trials included in Cochrane reviews: protocol for a meta-epidemiological study.
Hansen JB; Juhl CB; Boutron I; Tugwell P; Ghogomu EAT; Pardo Pardo J; Rader T; Wells GA; Mayhew A; Maxwell L; Lund H; Christensen R;
BMJ Open; 2014 Oct; 4(10):e005491. PubMed ID: 25280805
[TBL] [Abstract][Full Text] [Related]
7. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
[TBL] [Abstract][Full Text] [Related]
8. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants for male subfertility.
Showell MG; Mackenzie-Proctor R; Brown J; Yazdani A; Stankiewicz MT; Hart RJ
Cochrane Database Syst Rev; 2014; (12):CD007411. PubMed ID: 25504418
[TBL] [Abstract][Full Text] [Related]
10. Ten questions to consider when interpreting results of a meta-epidemiological study-the MetaBLIND study as a case.
Moustgaard H; Jones HE; Savović J; Clayton GL; Sterne JA; Higgins JP; Hróbjartsson A
Res Synth Methods; 2020 Mar; 11(2):260-274. PubMed ID: 31851427
[TBL] [Abstract][Full Text] [Related]
11. Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study.
Tzoulaki I; Siontis KC; Ioannidis JP
BMJ; 2011 Nov; 343():d6829. PubMed ID: 22065657
[TBL] [Abstract][Full Text] [Related]
12. Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?
Golder S; Loke YK
Br J Clin Pharmacol; 2008 Dec; 66(6):767-73. PubMed ID: 18754841
[TBL] [Abstract][Full Text] [Related]
13. Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study.
Moustgaard H; Clayton GL; Jones HE; Boutron I; Jørgensen L; Laursen DRT; Olsen MF; Paludan-Müller A; Ravaud P; Savović J; Sterne JAC; Higgins JPT; Hróbjartsson A
BMJ; 2020 Jan; 368():l6802. PubMed ID: 31964641
[TBL] [Abstract][Full Text] [Related]
14. Topics and PRISMA Checklist Compliance for Meta-analyses in Dermatology: Journal Case Study.
Poveda-Montoyo I; Belinchón-Romero I; Romero-Pérez D; Ramos-Rincón JM
Acta Dermatovenerol Croat; 2019 Dec; 27(4):275-277. PubMed ID: 31969243
[TBL] [Abstract][Full Text] [Related]
15. Methodological characteristics and treatment effect sizes in oral health randomised controlled trials: Is there a relationship? Protocol for a meta-epidemiological study.
Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; Flores-Mir C
BMJ Open; 2014 Feb; 4(2):e004527. PubMed ID: 24568962
[TBL] [Abstract][Full Text] [Related]
16. Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study.
Bafeta A; Dechartres A; Trinquart L; Yavchitz A; Boutron I; Ravaud P
BMJ; 2012 Feb; 344():e813. PubMed ID: 22334559
[TBL] [Abstract][Full Text] [Related]
17. Quantifying bias in randomized controlled trials in child health: a meta-epidemiological study.
Hartling L; Hamm MP; Fernandes RM; Dryden DM; Vandermeer B
PLoS One; 2014; 9(2):e88008. PubMed ID: 24505351
[TBL] [Abstract][Full Text] [Related]
18. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
19. Registered trials report less beneficial treatment effects than unregistered ones: a meta-epidemiological study in orthodontics.
Papageorgiou SN; Xavier GM; Cobourne MT; Eliades T
J Clin Epidemiol; 2018 Aug; 100():44-52. PubMed ID: 29705094
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
